Gossamer Bio GOSS will release its quarterly earnings report on Thursday, 2025-05-15. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Gossamer Bio to report an earnings per share (EPS) of $-0.19.
Investors in Gossamer Bio are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings Track Record
In the previous earnings release, the company beat EPS by $0.02, leading to a 11.54% increase in the share price the following trading session.
Here's a look at Gossamer Bio's past performance and the resulting price change:
Quarter | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
EPS Estimate | -0.17 | -0.15 | 0.23 | -0.18 |
EPS Actual | -0.15 | -0.14 | 0.22 | -0.19 |
Price Change % | 12.0% | -1.0% | 4.0% | 3.0% |
Stock Performance
Shares of Gossamer Bio were trading at $1.09 as of May 13. Over the last 52-week period, shares are up 40.41%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for Gossamer Bio visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.